Advertisements

Асентра

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Асентра

Property Description
Active ingredient Sertraline (Sertraline Hydrochloride)
Form Oral tablet (typically film-coated)
Pharmacological class Selective Serotonin Reuptake Inhibitor (SSRI)
Common use Modulation of mood and emotional stability
Origin Synthetic compound

What Type of Medicine Is Асентра and What Does It Contain?

Асентра is a prescription-only synthetic medicinal product that utilizes the active ingredient Sertraline, which is typically administered as the hydrochloride salt. It is formally classified as an antidepressant belonging to the pharmacological group of Selective Serotonin Reuptake Inhibitors (SSRIs). The specific Асентра formulation is presented as a single-ingredient oral tablet, a standard presentation for consistent delivery of Sertraline. This synthetic structure, derived from a naphthalenamine derivative, supports its pharmaceutical profile.

Classification and General Purpose of SSRIs

The core function of Sertraline is centered on the selective regulation of serotonin, a critical chemical messenger within the central nervous system. This SSRI mechanism is characterized by its action in modulating neurotransmitter availability. The medicine is used to support neurochemical stability, specifically targeting imbalances in emotional pathways. The general therapeutic purpose is to aid in stabilizing mood and enhancing emotional resilience, which is often necessary during periods of significant psychological distress.

Physical Form and Delivery

The pharmaceutical form of Асентра is a standardized solid unit designed for oral administration, most commonly manufactured as a film-coated tablet. This established oral delivery route is essential for maintaining the stable systemic concentrations required to achieve the sustained therapeutic effects of the psychotropic agent, Sertraline. The consistent tablet format ensures reliable dosing, which is a key factor in patient adherence.

Advertisements

What side effects are possible with Асентра?

Possible side effects and safety information

The safety profile of sertraline is officially documented across regulatory sources and provides classification of possible adverse reactions based on frequency and affected physiological systems. Adverse effects are organized into categories, primarily involving the nervous, gastrointestinal, and reproductive systems, derived from clinical data.

Officially classified adverse reactions include those designated as Very Common (ge 10%), such as nausea, insomnia, diarrhea, and ejaculation failure in males. Reactions classified as Common (ge 1% to <10%) include dry mouth, fatigue, somnolence, tremor, decreased appetite, and increased sweating.

System-Organ Class Examples of Documented Adverse Reactions
Gastrointestinal Disorders Nausea, Diarrhea, Dry Mouth, Dyspepsia
Nervous System Disorders Headache, Tremor, Dizziness, Somnolence
Reproductive System Disorders Ejaculation Failure, Decreased Libido

Serious adverse reactions are specifically highlighted in regulatory documents. A Boxed Warning states an increased risk of suicidal thoughts and behaviors in children, adolescents, and young adults (up to 24 years), particularly during the initial months of therapy and after dosage changes. Other clinically significant risks include the potential for Serotonin Syndrome, the activation of Mania/Hypomania, and an increased risk of abnormal bleeding or hemorrhage.

Safety constraints define limitations for use, such as the official contraindication with Monoamine Oxidase Inhibitors (MAOIs) due to the risk of Serotonin Syndrome. Specific population considerations are also documented, including increased caution for older adults (risk of hyponatremia) and limitations for patients with severe hepatic impairment. Upon stopping treatment, the label notes the potential for a discontinuation syndrome.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for Sertraline (Асентра) overdose documents specific clinical manifestations and mandates immediate emergency intervention regardless of initial symptom severity.

Documented Overdose Manifestations

Overdosage may present with a spectrum of effects, including Central Nervous System (CNS) disturbances such as somnolence, dizziness, agitation, and fine tremor. Gastrointestinal symptoms, including nausea, vomiting, and diarrhea, are also commonly reported in official regulatory sources. Cardiovascular findings can include tachycardia (fast heart rate) and measurable QTc interval prolongation on an ECG.

Life-Threatening Risks and Mandated Emergency Actions

The official labeling identifies severe outcomes that may occur, including seizures, profound altered mental status, and coma. The development of Serotonin Syndrome is a documented risk, particularly in cases of multiple drug overdosage involving other serotonergic agents. Fatalities have been reported, especially when Sertraline is ingested with other compounds. For any suspected overdosage, immediate medical attention is required, and individuals must contact emergency services or a certified Poison Control Center immediately, as dictated by governmental guidelines.

Management Considerations

As no specific antidote is known for Sertraline overdose, management focuses on general symptomatic and supportive measures. Due to potential cardiac effects, continuous ECG monitoring is recommended. Gastrointestinal decontamination using activated charcoal may be considered in certain situations, but the induction of emesis (vomiting) is not recommended according to regulatory guidance.

Advertisements

Therapeutic Uses of Асентра

What Асентра treats: main uses and benefits

Sertraline is considered relevant for use across domains where additional symptomatic support is needed, assisting with maintaining functional stability. It is commonly used when supportive symptom management is appropriate for conditions involving episodic or fluctuating manifestations. The medication is relevant for use in conditions such as Major Depressive Disorder (MDD), Obsessive-Compulsive Disorder (OCD), Panic Disorder (PD), Post-Traumatic Stress Disorder (PTSD), Social Anxiety Disorder (SAD), and Premenstrual Dysphoric Disorder (PMDD).

Асентра is generally applied in contexts involving recurrent or episodic manifestations, helping address symptom clusters that may become intense or disruptive, such as persistent sadness, acute fear, or intrusive thoughts. The medication is used in areas where short-term symptom management is appropriate or when symptoms create noticeable functional strain. It provides support that helps ease the overall symptom burden, contributing to improved comfort during periods of heightened symptoms. This supportive relief may assist with maintaining functional stability during symptom fluctuations, such as acute panic or severe cyclical mood shifts.


Fact: Supportive Management for Symptom Patterns
Supports the management of persistent low mood, intense fear episodes, and ritualistic behaviors (compulsions).

Regulatory References

  1. NIH MedlinePlus overview
Advertisements

Eligibility and Restrictions for Use

The official eligibility profile for Aсентра (Sertraline) is strictly defined by regulatory documents, which mandate specific constraints on who can use the medicine.

Contraindications and Prohibited Use

The medicine must not be used by patients with known hypersensitivity to Sertraline or its components. It is also contraindicated for those currently receiving Monoamine Oxidase Inhibitors (MAOIs), including Linezolid and Methylene Blue, or the medicine Pimozide.

Age-Group Eligibility

Use is approved for adults (18 years and older) for all labeled indications. In pediatric patients (ages 6–17), official approval is restricted to the treatment of Obsessive-Compulsive Disorder (OCD) only. Safety and effectiveness have not been established for children under six years of age.

Conditional Use and Restrictions

Patients with severe hepatic impairment are generally not recommended to use the medicine due to lack of established data. Caution is required in those with mild-to-moderate hepatic impairment. The medicine should be avoided in cases of unstable epilepsy. Eligibility during pregnancy and lactation is conditional, and use is stated to be considered only if the potential benefit justifies the potential risk.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Contraindicated Combinations

Use with Monoamine Oxidase Inhibitors (MAOIs) is strictly contraindicated due to the high risk of developing Serotonin Syndrome, which is a potentially life-threatening condition. A mandatory wash-out period is required when switching between this medication and an MAOI: 14 days must elapse after stopping an irreversible MAOI before starting treatment, and 7 days after stopping this medicine before starting an MAOI. The combination with Pimozide is also contraindicated.

Serotonergic and Bleeding Risk

Caution is warranted when combining with other serotonergic agents (such as triptans, other SSRIs, fentanyl, or St John's wort) as this also increases the likelihood of Serotonin Syndrome. Co-administration with drugs that affect platelet function or increase the risk of bleeding, including non-steroidal anti-inflammatory drugs (NSAIDs) and anticoagulants (like warfarin), requires careful monitoring of coagulation status.

Metabolic and Other Interactions

This medication is a mild-to-moderate inhibitor of the CYP2D6 enzyme system, which may increase the exposure of other medicines primarily metabolized by this pathway. Its use with alcohol is generally not recommended. If using the oral liquid formulation, co-administration with Disulfiram is contraindicated due to the presence of alcohol in the solution.

Advertisements

Mechanism of Action

Primary Action: Selective Serotonin Reuptake Inhibition

Асентра (Sertraline) exerts its initial molecular action by selectively inhibiting the Serotonin Transporter (SERT), a protein located on the pre-synaptic neuronal membrane. This inhibition prevents the active reuptake of the neurotransmitter serotonin (5-HT) from the synaptic cleft back into the neuron. The resulting sustained elevation of 5-HT concentration in the synapse leads to a more prolonged and enhanced stimulation of post-synaptic serotonin receptors.


Central Nervous System Adaptation and Modulation

Beyond the acute change in synaptic concentration, the drug's full effect requires slower, chronic cellular adaptation within the Central Nervous System (CNS). The sustained serotonergic enhancement triggers adaptive mechanisms, including the desensitization of inhibitory 5-HT1A autoreceptors and the upregulation of Brain-Derived Neurotrophic Factor (BDNF) signaling. These neuroplastic changes establish a new, altered state of central serotonergic tone. This modulation ultimately acts to adjust the firing patterns within circuits integral to limbic and hypothalamic function.

Advertisements

Dosage and Administration Information

How Асентра is Used

The administration of Sertraline (Асентра) follows a structured protocol to ensure consistent delivery. The medicine is for oral administration and is available in tablets, an oral solution concentrate, and capsules.


Official Dosing and Frequency

Daily use follows a once daily schedule. The initial starting dose for adults typically ranges from 25 mg to 50 mg per day, depending on the specific indication, and is gradually adjusted. The standard maintenance range is 50 mg to 200 mg per day, with 200 mg established as the maximum recommended daily amount. Any adjustment to the daily dose should occur at intervals of no less than one week to allow for the medicine to reach stable systemic concentrations.


Administration Conditions and Adjustments

The tablet form of the medicine may be taken with or without food. For the oral solution, dilution is required immediately before use with a non-alcoholic liquid, such as water or certain sodas; it must not be mixed with other solutions. Dose modification is required for certain groups; for instance, patients with mild hepatic impairment use a starting and maximum dosage that is half the standard dose. Furthermore, when treatment is to be concluded, the procedure involves a gradual reduction in dosage rather than abrupt cessation. If a dose is missed, the standard protocol is to continue with the next scheduled dose at the regular time the following day, without taking a double dose.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Асентра (Sertraline)

Evidence for Use in Major Depressive Disorder (MDD)

The evidence landscape for Sertraline's clinical evaluation in MDD is largely built upon short-term (8 to 12 week) Randomized Controlled Trials (RCTs). These studies were used in research exploring how symptoms change over time, comparing the observed populations with groups receiving an inactive substance. Outcomes were primarily measured using standardized scales that quantify the intensity of core depressive symptoms. Beyond acute treatment, studies also included longer continuation trials lasting many months, observing patterns related to the return or worsening of symptoms (relapse/recurrence).

Research describes changes measured during the study period for populations with MDD. Findings describe patterns observed in the studies related to measured symptom scores, contributing to the broader evidence landscape for conditions characterized by fluctuating manifestations. Long-term outcomes are not as well characterized over multiple years of use.

Evidence for Use in Anxiety and Related Disorders

Research has extensively explored Sertraline in conditions associated with acute or disruptive episodes, including Obsessive-Compulsive Disorder (OCD), Panic Disorder (PD), and Social Anxiety Disorder (SAD).

For OCD, research examined symptoms in both adults and pediatric patients (children and adolescents). The studies focused on outcomes describing episodic changes in the severity and frequency of obsessions and compulsions, which was measured using specific rating scales. Studies monitored symptom change and often required a longer duration of research observation in the observed populations. Evidence is limited regarding long-term outcomes and the durability of measured effects following the end of the observed study period.

For PD and SAD, Sertraline was studied for acute symptom change over short defined time intervals. Research examined outcomes capturing phases of heightened symptom activity, such as the frequency of panic attacks and functional measures related to avoidance behaviors. For long-term use in these conditions, regulatory sources have noted the necessity to re-examine the evidence periodically, as comparative evidence examining durability across studies is limited.

What is Still Uncertain About Асентра's Research Base

While research has been conducted across several conditions, some areas of uncertainty remain. Long-term outcomes are not as well characterized across all indications, particularly concerning the maintenance of observed effects over extended periods (years). Findings varied regarding the magnitude of measured changes compared to control groups in specific patient subgroups. Research describes group patterns and does not determine whether an individual will experience similar measured changes across all contexts.

Key Studies & References

  1. Sertraline as a treatment for PTSD: a systematic review and meta-analysis
  2. Sertraline Treatment of Posttraumatic Stress Disorder: Results of 24 Weeks of Open-Label Continuation Treatment (PTSD long-term study)
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Асентра (FAQ)


Q: How long does it usually take for Асентра to start working?

Official information indicates that initial benefits for symptoms like appetite and sleep may be observed within the first one or two weeks of treatment. However, the timeframe in which the full measured change is observed in clinical trials, particularly for conditions like Major Depressive Disorder, generally takes approximately four to six weeks of regular use. Conditions such as Obsessive-Compulsive Disorder may require a longer period before the full therapeutic benefit is observed.


Q: Is it common to feel worse when first starting Асентра?

Regulatory documents list several side effects, including increased anxiety and nausea, which are common when starting the medication. Official warnings also note that symptoms of depression or anxiety may worsen during the initial months of treatment, especially after dosage changes. Regulatory warnings indicate that patients must be monitored for new or worsening symptoms during this period.


Q: Is it true that Асентра can sometimes increase anxiety initially?

Yes, official product information indicates that new or worsening anxiety is a potential symptom that should be closely monitored when treatment begins or when the dosage is changed. This effect is a documented part of the adverse reaction profile.


Q: Is it necessary to take Асентра for a long time?

Regulatory documents describe that treatment following an acute episode of Major Depressive Disorder is typically extended for several months or longer in studies to observe patterns related to the risk of symptoms returning (relapse). For other approved conditions, the duration of use varies, and the necessity for continued therapy is regularly re-evaluated.


Q: What is the official recommended age for using Асентра?

Official product information confirms that this medication is approved for use in adults (18 years and older) for all labeled indications. In pediatric patients, use is strictly restricted to the treatment of Obsessive-Compulsive Disorder (OCD) for children and adolescents aged 6 to 17.


Q: What is the purpose of taking the medication at the same time each day?

Regulatory information related to the drug's action in the body (pharmacokinetics) explains that consistent daily use is needed to help the medicine reach and maintain stable levels in the bloodstream. This consistent timing supports the maintenance of stable concentrations, which aligns with the way the medication was studied in clinical trials.


Q: Does Асентра affect the ability to concentrate?

Official warnings state that drugs acting on the central nervous system may affect an individual's ability to think clearly. Patients are advised to be cautious when performing tasks that require mental alertness, such as driving or operating heavy equipment, until they understand how this medicine affects them personally.


Q: How long does it take for Асентра to leave the system after stopping?

The active ingredient, sertraline, has an average half-life of about 26 hours, meaning it takes roughly that long for half of the dose to be eliminated from the body. However, its major active byproduct can take much longer to leave the system entirely. For this reason, official guidelines indicate that stopping the treatment involves a gradual reduction in dosage.


Q: Does Асентра affect blood pressure?

While not a common side effect of routine use, official warnings for a rare, serious condition called Serotonin Syndrome note that symptoms can include major changes in blood pressure. The potential for this interaction emphasizes the importance of medical monitoring, especially when the medicine is combined with other serotonergic agents.


Q: What is the main difference between Асентра and other SSRIs?

Official sources classify Асентра as a Selective Serotonin Reuptake Inhibitor (SSRI), meaning it operates using the same core mechanism as others in this class. While the mechanism is shared, studies and clinical experience indicate that SSRIs may vary in effectiveness for specific conditions, their side effect profile, and their propensity for interacting with other medicines.


Q: Does Асентра cause weight gain, or is weight loss possible?

Official documents list decreased appetite as a common side effect. Although specific weight changes are not listed among the most frequent adverse reactions, official reports from clinical trials and post-marketing experience have noted both weight gain and weight loss in some patient populations.


Q: Can Асентра affect sleep patterns?

Yes, regulatory documentation explicitly lists adverse reactions related to sleep. These include insomnia (difficulty falling or staying asleep) as a Very Common side effect and somnolence (sleepiness) as a Common side effect.


Q: Can Асентра be taken by someone who is elderly?

Regulatory documents state that this medication is generally effective and tolerated in elderly patients (e.g., those 60 years of age and older). While dosage adjustments are typically not required solely due to age, caution is advised because this group may have an increased risk of hyponatremia (low sodium levels).


Q: Does Асентра cause hair loss?

Alopecia, which is the medical term for hair loss, has been reported in post-marketing experience. This means that while it is not listed among the very common or common side effects, it has been observed and reported in patients after the drug was approved.


Q: Do studies suggest that Асентра is effective for panic attacks?

Regulatory documentation indicates that the medicine is approved and clinically indicated for the treatment of Panic Disorder. Evidence from controlled studies supports its use for reducing the severity and frequency of panic attacks.


Q: Is there a risk of developing a dependency on Асентра?

Official sources do not classify this medicine as a controlled substance. While the regulatory documentation does not classify the drug as having a high risk for abuse, the potential for a discontinuation syndrome upon abrupt cessation is noted, which requires a gradual reduction in use.


Q: Can I drive or operate machinery while taking Асентра?

Patients should be advised to exercise caution when operating hazardous machinery, including driving a motor vehicle, until they are reasonably certain that the medication does not adversely affect their ability to perform such activities.


Q: Why do some people experience stomach issues when starting Асентра?

Gastrointestinal issues, such as nausea and diarrhea, are very common adverse reactions. These effects are thought to be related to the drug's core mechanism of action, which involves serotonin—a neurotransmitter largely present in the digestive tract. These issues often lessen as the body adjusts to the medicine.


Q: Is it possible to take herbal supplements while on Асентра?

Official warnings specifically advise against the use of the herbal supplement St. John's wort. This is due to the potential for it to increase the overall serotonergic effects of the medicine, which raises the risk of a serious drug interaction called Serotonin Syndrome.


Q: What kind of monitoring is needed when taking Асентра?

Monitoring is required for several conditions, including the emergence of new or worsening suicidal thoughts, symptoms of mania, and abnormal bleeding. If the medicine is combined with agents that affect blood clotting, such as warfarin, regular monitoring of coagulation status may be necessary.


Q: Will Асентра stop working over time?

Official studies designed to evaluate long-term use describe that the measured effects were maintained for extended periods in the populations observed during continuation trials. However, the regulatory documentation advises that the risk of symptom recurrence (relapse) should still be monitored as part of standard medical practice.


Q: Is Асентра known to interact with commonly used pain relievers?

Official warnings recommend caution when combining this medicine with non-steroidal anti-inflammatory drugs (NSAIDs). The combination of these agents carries a documented increased risk of bleeding due to their combined effect on blood platelet function.


Q: Do I need to change my diet while taking Асентра?

No specific dietary changes are generally required for the tablet form, which can be taken with or without food. However, official information strongly recommends avoiding alcohol, and for the liquid formulation, use with Disulfiram is strictly prohibited.


Q: Is Асентра considered a high-risk medication?

The medicine is associated with serious warnings, including a Boxed Warning regarding the increased risk of suicidal thoughts and behaviors in young adults. It is not classified as a controlled substance, but its risk profile includes specific contraindications that must be observed.


Q: Is it common to have vivid dreams or nightmares while taking Асентра?

Abnormal changes to dreams, including experiencing vivid dreams, have been reported in post-marketing experience. This is considered an uncommon to rare side effect and is not listed among the very common or common categories.


Q: Can Асентра be used by someone with bipolar disorder?

Official documentation notes that using sertraline to treat depression in a patient with bipolar disorder may potentially trigger a manic or hypomanic episode. For this reason, official documentation advises that a patient should be screened for any personal or family history of bipolar disorder, mania, or hypomania prior to starting treatment.


Q: Does Асентра affect fertility in men or women?

Studies in animals have shown that sertraline may affect sperm quality. While the full impact on human fertility is not fully established, common side effects such as decreased libido and ejaculation failure are documented as potentially affecting sexual function.


Q: What official studies address the effects of Асентра on children?

Official studies established the safety and effectiveness of the medicine in children and adolescents (ages 6–17) only for the treatment of Obsessive-Compulsive Disorder (OCD). Studies in this age group noted risks of weight loss and decreased appetite.


Q: Does Асентра affect blood sugar levels?

Regulatory documents indicate that the medicine may affect blood sugar levels. Caution is advised when it is taken alongside medications for diabetes (such as insulin or oral hypoglycemic agents), as this combination may increase the risk of developing low blood sugar (hypoglycemia).


Q: What is the typical expected duration of treatment with Асентра?

For Major Depressive Disorder, it is generally agreed that successful treatment of an acute episode requires sustained therapy for several months or longer after initial improvement. The duration of long-term treatment is determined by the patient's condition and the medical assessment of their risk for symptoms returning.

Advertisements

How should Асентра be stored and disposed of?

The official regulatory documents specify precise conditions for the storage and disposal of Asentra (Sertraline) tablets.

Storage Conditions

Requirement Official Statement
Temperature Store at controlled room temperature, typically 20 C to 25 C.
Protection Keep the medication away from excess heat and moisture (not in the bathroom).
Packaging Keep the tablets in the original container, tightly closed.
Child Safety Store medication out of the sight and reach of children.

Disposal Instructions

The most appropriate method for disposal is through an official drug take-back program. Asentra is not on the FDA's flush list and should not be flushed down the toilet.

If a take-back option is unavailable, the official guidance is to mix the unused tablets with an undesirable substance (like coffee grounds or dirt) and place the mixture in a sealed container before discarding it in the household trash. Personal information on the prescription label must be completely scratched out prior to disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Асентра found in:

A-Z Index: